Susan M Fisher

US Patent:

7175990, Feb 13, 2007

Filed:

Feb 25, 2003

Appl. No.:

10/374318

Inventors:

Susan J. Fisher - San Francisco CA, US
Olga Genbacev-Krtolica - Los Gatos CA, US
Akraporn Prakobphol - Folsom CA, US
Michael T. McMaster - Oakland CA, US

Assignee:

The Regents of the University of California - Oakland CA

International Classification:

G01N 33/53

US Classification:

435 71, 435 792, 4241371

Abstract:

The present invention provides a method of predicting the probability of a successful pregnancy, either a naturally achieved pregnancy or a pregnancy resulting from an assisted reproductive technology, based on the level of L-selectin ligand expressed by uterine epithelial cells and/or the level of L-selectin expressed by an embryo in vitro. The invention further provides methods of inhibiting cell adhesion between a trophoblast and a uterine epithelial cell. Methods of inhibiting cell adhesion between a trophoblast and a uterine epithelial cell are useful to inhibit pregnancy. The invention further provides methods of assessing in vitro embryo quality. The invention further provides methods of predicting the probability of continued success of a pregnancy during the first 16 weeks of gestation.

US Patent:

20080233583, Sep 25, 2008

Filed:

Feb 20, 2008

Appl. No.:

12/034458

Inventors:

Susan J. Fisher - San Francisco CA, US
Virginia D. Winn - Denver CO, US
Ronit Haimov-Kochman - Mevasseret Zion, IL

Assignee:

REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA

International Classification:

C12Q 1/68
G01N 33/566
G01N 33/50
G01N 33/567

US Classification:

435 6, 436501, 436 94, 435 721

Abstract:

The present invention provides methods for predicting the development of and diagnosing preeclampsia, providing a prognosis, and predicting recurrence of the disease using molecular markers that are overexpressed or underexpressed in preeclampia. Also provided are methods to identify compounds that are useful for the treatment or prevention of preeclampsia.

US Patent:

20210115126, Apr 22, 2021

Filed:

Sep 24, 2020

Appl. No.:

17/031468

Inventors:

- South San Francisco CA, US
Saloumeh Kadkhodayan Fischer - Castro Valley CA, US
Susan C. Fisher - San Carlos CA, US
John Lowe - Pleasanton CA, US
Atia Naim - Mountain View CA, US
Ailen M. Sanchez - Foster City CA, US
Christopher A. Teske - San Mateo CA, US
Martin Vanderlaan - San Francisco CA, US
Annamarie Amurao - Belmont CA, US
Jayme Franklin - San Mateo CA, US
Corazon Victa - Walnut Creek CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C07K 16/24
C07K 16/06
C07K 16/08
C07K 16/40
C07K 1/18
C07K 1/22
C07K 1/36
C07K 16/18

Abstract:

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.

US Patent:

20200271660, Aug 27, 2020

Filed:

Sep 5, 2018

Appl. No.:

16/644544

Inventors:

- Valencia, ES
Susan Fisher - San Francisco CA, US
Tamara Garrido - Valencia, ES

Assignee:

IGENOMIX S.L. - Valencia

International Classification:

G01N 33/68
C12Q 1/686
C12Q 1/6813
G01N 33/543

Abstract:

Provided herein, in some embodiments, are methods and compositions for detecting differentially expressed genes in a sample obtained from a subject having or at risk for preeclampsia.

US Patent:

20180291095, Oct 11, 2018

Filed:

Feb 22, 2018

Appl. No.:

15/902145

Inventors:

- South San Francisco CA, US
Saloumeh Kadkhodayan Fischer - Castro Valley CA, US
Susan C. Fisher - San Carlos CA, US
John Lowe - Pleasanton CA, US
Atia Naim - Mountain View CA, US
Ailen M. Sanchez - Foster City CA, US
Christopher A. Teske - San Mateo CA, US
Martin Vanderlaan - San Francisco CA, US
Annamarie Amurao - Belmont CA, US
Jayme Franklin - San Mateo CA, US
Corazon Victa - Walnut Creek CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C07K 16/24
C07K 16/40
C07K 1/18
C07K 1/22
C07K 1/36
C07K 16/06
C07K 16/08
C07K 16/18
A61K 39/00

Abstract:

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.

US Patent:

20180273615, Sep 27, 2018

Filed:

Feb 1, 2018

Appl. No.:

15/886277

Inventors:

- South San Francisco CA, US
Saloumeh Kadkhodayan Fischer - Castro Valley CA, US
Susan C. Fisher - San Carlos CA, US
John Lowe - Pleasanton CA, US
Ailen M. Sanchez - Foster City CA, US
Martin Vanderlaan - San Francisco CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C07K 16/24
C07K 16/40
C07K 1/18
C07K 1/22
C07K 1/36
C07K 16/06
C07K 16/08
C07K 16/18
A61K 39/00

Abstract:

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.

US Patent:

20160319012, Nov 3, 2016

Filed:

Mar 9, 2016

Appl. No.:

15/065693

Inventors:

- South San Francisco CA, US
Saloumeh Kadkhodayan Fischer - Castro Valley CA, US
Susan C. Fisher - San Carlos CA, US
John Lowe - Pleasanton CA, US
Atia Naim - Mountain View CA, US
Ailen M. Sanchez - Foster City CA, US
Christopher A. Teske - San Mateo CA, US
Martin Vanderlaan - San Francisco CA, US
Annamarie Amurao - Belmont CA, US
Jayme Franklin - San Mateo CA, US
Corazon Victa - Walnut Creek CA, US

Assignee:

Genentech, Inc. - South San Francisco CA

International Classification:

C07K 16/24
C07K 1/36
C07K 1/22
C07K 1/18
C07K 16/18

Abstract:

Purified recombinant polypeptides isolated from Chinese hamster ovary host cells, including antibodies, such as therapeutic antibodies, and methods of making and using such polypeptides are provided.